A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cor Medix Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 30,061 shares of CRMD stock, worth $300,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,061
Previous 27,659 8.68%
Holding current value
$300,008
Previous $119,000 103.36%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.64 - $8.23 $8,743 - $19,768
2,402 Added 8.68%
30,061 $242,000
Q2 2024

Aug 14, 2024

BUY
$4.08 - $6.39 $112,848 - $176,741
27,659 New
27,659 $119,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $411M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.